“Pyrotinib: A Promising Tyrosine Kinase Inhibitor for Treating Breast Cancer”. Molecular Medicine Communications 4, no. 01 (June 7, 2024): 43–57. Accessed April 3, 2026. https://rootspress.org/journals/MMC/article/view/553.